Clinical trial
Double-Blind, Acute Depression Study Comparing Venlafaxine XR and Lamotrigine When Added to Mood Stabilizer in the Treatment of Bipolar Depression
NCT00188643 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind, Acute Depression Study Comparing Venlafaxine XR and Lamotrigine When Added to Mood Stabilizer in the Treatment of Bipolar Depression
- Lead sponsor
- University Health Network, Toronto
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2002
- Completion date
- January 31, 2007
- Enrollment
- 40
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.